Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 0 |
Search Results
2 results
Results by year
Citations
1 article found by citation matching
Efficacy of high-dose chemotherapy and autologous stem cell transplant for recurrent Wilms' tumor: a meta-analysis.
J Pediatr Hematol Oncol. 2010.
PMID: 20505538
Search results
Filters applied: . Clear all
Page 1
Efficacy of high-dose chemotherapy and autologous stem cell transplant for recurrent Wilms' tumor: a meta-analysis.
Presson A, Moore TB, Kempert P.
Presson A, et al.
J Pediatr Hematol Oncol. 2010 Aug;32(6):454-61. doi: 10.1097/MPH.0b013e3181e001c2.
J Pediatr Hematol Oncol. 2010.
PMID: 20505538
Long-term survival of relapsed Wilms' tumor patients is about 40% to 70%. Modern second-line treatment consists of either (a) salvage chemotherapy+/-radiation therapy (CT) or (b) chemotherapy followed by high-dose chemotherapy and …
Long-term survival of relapsed Wilms' tumor patients is about 40% to 70%. Modern second-line treatment consists of either (a) salvage …
Item in Clipboard
High-dose chemotherapy followed by autologous stem cell rescue in Wilms tumors: French report on toxicity and efficacy.
Delafoy M, Verschuur A, Scheleirmacher G, Tabone MD, Sudour-Bonnange H, Thébaud E, Freycon C, Notz-Carrère A, Boulanger C, Pellier I, Irtan S, Muracciole X, Coulomb-L'Hermine A, Dijoud F, Morelle M, Bergeron C, Pasqualini C.
Delafoy M, et al.
Pediatr Blood Cancer. 2022 Mar;69(3):e29431. doi: 10.1002/pbc.29431. Epub 2021 Nov 22.
Pediatr Blood Cancer. 2022.
PMID: 34811873
BACKGROUND: Heterogeneous data have been reported on high-dose chemotherapy (HDCT) with autologous stem cell rescue (ASCR) in Wilms tumors (WTs). We aimed to define its safety and efficacy in the French cohort, and to compar …
BACKGROUND: Heterogeneous data have been reported on high-dose chemotherapy (HDCT) with autologous stem …
Item in Clipboard
Cite
Cite